Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Reliance Life Sciences Private Limited recalls Bortezomib for Injection 3.5mg/Vial

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Sterility Assurance
Products
  • Bortezomib for Injection 3.5mg/Vial
Where it was sold

Nationwide in the USA

Nationwide

Units affected
11,400 vials
About this recall
Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01